[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100631876":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":21,"responsibleParty":42,"collaborators":10,"id":44,"slug":10,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":10,"enrollmentInfo":52,"targetDuration":55,"studyType":56,"phases":10,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":24,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"University Hospital, Montpellier","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"patients with indication of TAVR - supra annular design device",null,"TAVR with self expandable supra annular design device (EVOLUT)",{"label":13,"type":10,"description":14,"interventionNames":10},"patients with indication of TAVR - intra annular design device","TAVR with self expandable intra annular design device",[16],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Florence LECLERCQ, MD","CONTACT","+33467336212","f-leclercq@chu-montpellier.fr",[22],{"facility":23,"status":24,"city":25,"state":26,"zip":27,"country":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"University hopsital","RECRUITING","Montpellier","Occitanie","34295","France",{"type":30,"coordinates":31},"Point",[32,33],3.87635,43.61093,{"lat":33,"lon":32},[36,39,40],{"name":37,"role":18,"phone":38,"phoneExt":10,"email":20},"FLORENCE LECLERCQ, MD, PhD","0681055297",{"name":10,"role":18,"phone":10,"phoneExt":10,"email":20},{"name":37,"role":41,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":43,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100631876",false,"NCT07506382","Comparative Observational Study of Supra-annular Versus Intra-annular Self-expanding Aortic Valves in Routine Clinical Practice","NEOVALVE","Inclusion Criteria:\n\n* all patients elligible for TAVR witn a self expandable device\n\nExclusion Criteria:\n\n* femoral access not suitable\n* valve in valve procedures","ALL","18 Years",{"count":53,"type":54},419,"ESTIMATED","36 Months","OBSERVATIONAL","We proposed to compare in an observational study procedural success at one month (VARC 3 criteria) and clinical and echographic follow-up at 6 months between 2 self expandable devices in TAVR : the supra annular Evolut device (Medtronic) vs the intra anular NAVITOR device (Abott)",[59],"Trans-catheter Aortic Valve Implantation",[61,62,63,64,65],"self expandable devices","intra annular design","supra annular design","procedural success","hemodynamics","2026-03-26",{"date":68,"type":69},"2026-04-01","ACTUAL",{"date":71,"type":69},"2026-02-10",{"date":73,"type":54},"2028-03",{"name":5,"class":6},1]